Antiviral Therapy

Yayıncı: Sage Publications
Ülke: United Kingdom · Western Europe
Tür: journal
ISSN: 13596535

20402058

Scopus 0,836 SJR

Scopus Q2 SJR Q

WoS Q2 JCR Q

WoS 3,3 JIF

Scopus 96 H-Index

Bütünleşik değerlendirme

Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.

WoS / JCR verileri 1997 ve sonrası içindir.

Scopus

Scopus · Scimago

SJR 0,836
Quartile Q2
H-Index 96
Atıf/yayın 3,34
Doküman (3y) 74
Atıf (3y) 194

Clarivate

Web of Science · JCR · 2025

JCR Q Q2
JIF 3,3
5Y JIF 2,1
JCI 0,51

WoS indeksleri

SCIE

Konu sınıflandırması

Kategoriler (SJR)

Infectious Diseases Q2
Pharmacology Q2
Pharmacology (medical) Q2

Alanlar

Medicine
Pharmacology, Toxicology and Pharmaceutics

WoS kategorileri

Infectious Diseases | Pharmacology & Pharmacy | Virology

Yıllık quartile karşılaştırması

Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: JCR Q, JIF, 5Y JIF, JCI ve JCI Q sütunları 1997 öncesi için boştur — bu sitede WoS/JCR verisi 1997’den başlar.
Yıl	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q2	Q2	0,836	3,3	2,1	0,51	Q3	96
2024	Q2	Q3	0,627	2,3	1,7	0,41	Q3	94
2023	Q3	Q4	0,447	1,3	1,5	0,22	Q4	94
2022	Q3	Q4	0,46	1,2	1,5	0,29	Q4	94
2021	Q2	Q4	0,835	1,7	2,1	0,52	Q3	94
2020	Q2	Q3	0,747	2,4	2,1	0,64	Q3	94
2019	Q2	Q3	0,753	2	1,7	0,7	Q2	94
2018	—	Q3	—	2,3	2	0,71	Q2	—
2017	Q2	Q3	0,958	2,1	2,1	0,69	Q3	94
2016	Q1	Q2	1,247	2,6	2,5	—	—	94
2015	Q1	Q2	1,388	2,9	2,7	—	—	94
2014	Q1	Q2	1,541	3	2,9	—	—	94
2013	Q1	Q2	1,554	3,1	3,1	—	—	94
2012	Q1	Q2	1,303	3,1	3,4	—	—	94
2011	Q1	Q2	1,515	3,2	3,6	—	—	94
2010	Q1	Q1	1,852	3,8	3,7	—	—	94
2009	—	Q1	—	4,3	3,7	—	—	—
2008	—	Q1	—	4,1	4	—	—	—
2007	—	Q1	—	4,5	4,6	—	—	—
2006	—	Q1	—	5	—	—	—	—
2005	—	Q1	—	5,3	—	—	—	—
2004	—	Q1	—	6	—	—	—	—
2003	—	Q1	—	5,9	—	—	—	—
2002	—	Q1	—	6,6	—	—	—	—
2001	—	Q1	—	9,2	—	—	—	—
2000	—	Q1	—	4,5	—	—	—	—

JCR kategori quartile geçmişi

Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: Bu tablo 1997+ Clarivate kategori quartile kayıtlarını gösterir.
Yıl	Kategori	Edition	JCR Q (1997+)	JCI Q (1997+)	Sıra
2025	INFECTIOUS DISEASES	SCIE	Q2	Q3	53/141
2025	PHARMACOLOGY & PHARMACY	SCIE	Q2	Q3	149/356
2025	VIROLOGY	SCIE	Q2	Q3	20/44
2024	INFECTIOUS DISEASES	SCIE	Q3	Q4	76/137
2024	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q4	202/352
2024	VIROLOGY	SCIE	Q3	Q3	24/42
2023	INFECTIOUS DISEASES	SCIE	Q4	Q4	112/132
2023	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q4	283/354
2023	VIROLOGY	SCIE	Q4	Q4	37/41
2022	INFECTIOUS DISEASES	SCIE	Q4	Q4	90/96
2022	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q4	256/278
2022	VIROLOGY	SCIE	Q4	Q4	34/36
2021	INFECTIOUS DISEASES	SCIE	Q4	Q3	87/95
2021	PHARMACOLOGY & PHARMACY	SCIE	Q4	Q3	245/279
2021	VIROLOGY	SCIE	Q4	Q3	35/37
2020	INFECTIOUS DISEASES	SCIE	Q4	Q3	70/93
2020	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	204/276
2020	VIROLOGY	SCIE	Q3	Q3	27/37
2019	INFECTIOUS DISEASES	SCIE	Q4	Q3	72/92
2019	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	194/271
2019	VIROLOGY	SCIE	Q3	Q3	27/37
2018	INFECTIOUS DISEASES	SCIE	Q3	Q3	56/89
2018	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	156/267
2018	VIROLOGY	SCIE	Q3	Q3	23/36
2017	INFECTIOUS DISEASES	SCIE	Q3	Q3	56/88
2017	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	159/261
2017	VIROLOGY	SCIE	Q3	Q3	24/35
2016	INFECTIOUS DISEASES	SCIE	Q2	—	41/84
2016	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	118/257
2016	VIROLOGY	SCIE	Q3	—	20/34
2015	INFECTIOUS DISEASES	SCIE	Q2	—	28/83
2015	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	81/255
2015	VIROLOGY	SCIE	Q2	—	15/33
2014	INFECTIOUS DISEASES	SCIE	Q2	—	28/78
2014	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	78/255
2014	VIROLOGY	SCIE	Q2	—	15/33
2013	INFECTIOUS DISEASES	SCIE	Q2	—	24/72
2013	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	68/256
2013	VIROLOGY	SCIE	Q3	—	17/33
2012	INFECTIOUS DISEASES	SCIE	Q2	—	22/70
2012	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	72/261
2012	VIROLOGY	SCIE	Q2	—	13/34
2011	INFECTIOUS DISEASES	SCIE	Q2	—	23/70
2011	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	68/261
2011	VIROLOGY	SCIE	Q2	—	15/32
2010	INFECTIOUS DISEASES	SCIE	Q2	—	15/58
2010	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	50/252
2010	VIROLOGY	SCIE	Q2	—	10/33
2009	INFECTIOUS DISEASES	SCIE	Q1	—	8/57
2009	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	33/237
2009	VIROLOGY	SCIE	Q1	—	6/30
2008	INFECTIOUS DISEASES	SCIE	Q1	—	9/51
2008	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	38/219
2008	VIROLOGY	SCIE	Q1	—	5/27
2007	INFECTIOUS DISEASES	SCIE	Q1	—	7/50
2007	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	22/205
2007	VIROLOGY	SCIE	Q1	—	4/25
2006	INFECTIOUS DISEASES	SCIE	Q1	—	6/47
2006	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	22/199
2006	VIROLOGY	SCIE	Q1	—	4/23
2005	INFECTIOUS DISEASES	SCIE	Q1	—	5/43
2005	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	16/193
2005	VIROLOGY	SCIE	Q1	—	3/23
2004	INFECTIOUS DISEASES	SCIE	Q1	—	2/41
2004	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	13/187
2004	VIROLOGY	SCIE	Q1	—	1/22
2003	INFECTIOUS DISEASES	SCIE	Q1	—	1/41
2003	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	10/185
2003	VIROLOGY	SCIE	Q1	—	1/23
2002	INFECTIOUS DISEASES	SCIE	Q1	—	1/38
2002	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	5/188
2002	VIROLOGY	SCIE	Q1	—	1/24
2001	INFECTIOUS DISEASES	SCIE	Q1	—	1/37
2001	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	4/186
2001	VIROLOGY	SCIE	Q1	—	1/25
2000	INFECTIOUS DISEASES	SCIE	Q1	—	4/36
2000	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	11/181
2000	VIROLOGY	SCIE	Q1	—	3/28